Follow
Peter Parry
Peter Parry
Associate Professor, University of Queensland; Visiting Senior Lecturer, Flinders University
Verified email at uq.edu.au - Homepage
Title
Cited by
Cited by
Year
From evidence-based medicine to marketing-based medicine: evidence from internal industry documents
GI Spielmans, PI Parry
Journal of Bioethical Inquiry 7, 13-29, 2010
1912010
Duty to warn: antidepressant black box suicidality warning is empirically justified
GI Spielmans, T Spence-Sing, P Parry
Frontiers in psychiatry 11, 18, 2020
582020
Pediatric bipolar disorder in an era of “mindless psychiatry”
PI Parry, EC Levin
Journal of Trauma & Dissociation 13 (1), 51-68, 2012
582012
The prevalence and treatment outcomes of antineuronal antibody-positive patients admitted with first episode of psychosis
JG Scott, D Gillis, AE Ryan, H Hargovan, N Gundarpi, G McKeon, ...
BJPsych open 4 (2), 69-74, 2018
572018
Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature
AC Tsai, NZ Rosenlicht, JN Jureidini, PI Parry, GI Spielmans, D Healy
PLoS medicine 8 (5), e1000434, 2011
522011
The autism spectrum disorder ‘epidemic’: Need for biopsychosocial formulation
S Basu, P Parry
Australian & New Zealand Journal of Psychiatry 47 (12), 1116-1118, 2013
282013
The paediatric bipolar hypothesis: the view from Australia and New Zealand
P Parry, G Furber, S Allison
Child and Adolescent Mental Health 14 (3), 140-147, 2009
282009
‘Paediatric bipolar disorder’rates are lower than claimed–a reexamination of the epidemiological surveys used by a meta‐analysis
P Parry, S Allison, T Bastiampillai
Child and Adolescent Mental Health 23 (1), 14-22, 2018
262018
Pre-pubertal paediatric bipolar disorder: a controversy from America
P Parry, S Allison
Australasian Psychiatry 16 (2), 80-84, 2008
252008
Psychotropic marketing practices and problems: Implications for DSM-5
M Raven, P Parry
The Journal of nervous and mental disease 200 (6), 512-516, 2012
232012
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
PI Parry, A Lefringhausen, C Turni, CJ Neil, R Cosford, NJ Hudson, ...
Biomedicines 11 (8), 2287, 2023
212023
Debate: Bipolar disorder: extremely rare before puberty and antipsychotics cause serious harms–a commentary on Van Meter et al.(2019)
P Parry, S Allison, T Bastiampillai
Child and Adolescent Mental Health 24 (1), 92-94, 2019
202019
Detached from attachment: Neurobiology and phenomenology have a human face
P Dignam, P Parry, M Berk
Acta Neuropsychiatrica 22 (4), 202-206, 2010
142010
‘Pediatric Bipolar Disorder’rates are still lower than claimed: a re-examination of eight epidemiological surveys used by an updated meta-analysis
P Parry, S Allison, T Bastiampillai
International Journal of Bipolar Disorders 9 (1), 21, 2021
122021
Reification of the paediatric bipolar hypothesis in the USA
PI Parry, S Allison, T Bastiampillai
The Lancet Psychiatry 2 (1), 14-16, 2015
92015
Conflict of interest as a possible factor in the rise of pediatric bipolar disorder
E C Levin, P I Parry
Adolescent Psychiatry 1 (1), 61-66, 2011
92011
Paediatric Bipolar Disorder–Are Attachment and Trauma Factors Considered?
PI Parry
Bipolar Disorder-A Portrait of a Complex Mood Disorder, 2012
82012
Can antipsychotic medication administered for paediatric emotional and behavioural disorders lead to brain atrophy?
T Bastiampillai, P Parry, S Allison
Australian & New Zealand Journal of Psychiatry 53 (6), 499-500, 2018
72018
Lacunae in the evidence for pediatric bipolar disorder: A response to the ISBD Task Force Report
P Parry, S Allison, T Bastiampillai
Bipolar disorders 20 (7), 581-582, 2018
62018
Lacunae in the evidence for pediatric bipolar disorder: A response to the ISBD Task Force Report
P Parry, S Allison, T Bastiampillai
Bipolar disorders 20 (7), 581-582, 2018
62018
The system can't perform the operation now. Try again later.
Articles 1–20